Gabapentinoids for Pruritus in Older Adults: Dermatological Applications
Gabapentin and pregabalin show effectiveness in treating chronic pruritus of neuropathic origin, gaining popularity in dermatological practice for managing cutaneous symptoms in older adults, underscoring their therapeutic potential beyond traditional antiepileptic indications.
December 2021
Microbial Keratitis: Addressing the Growing Concerns in Contact Lens Wearers
Increasing use of contact lenses in children raises concerns about microbial keratitis, emphasizing the importance of preventive measures and vigilant eye care practices to minimize the risk of sight-threatening corneal infections.
December 2021
FDA and CDC Pause Use of Johnson & Johnson Vaccine: Safety Concerns
Following reports of rare blood clotting events, the FDA and CDC recommend a pause in the use of the Johnson & Johnson vaccine, highlighting the importance of post-authorization safety monitoring and rapid response to vaccine-related adverse events.
December 2021
Triple vs. Double Inhalation Therapy in Moderate to Severe Asthma: Comparative Efficacy and Safety
Triple therapy is associated with fewer severe exacerbations compared to double inhalation therapy in patients with moderate to severe asthma, supporting the use of combination therapy for optimized asthma control and reduced disease burden.
December 2021
